Canada - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use

Since 2014, Canada Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use was up 11.3% year on year. In 2019, the country was number 10 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use at 79.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Canada is overtaken by Sweden, which was ranked number 9 at 82.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Hungary with 79.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands lead the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria was the worst growing country at -14% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 79.70
2018 77.60
2017 77.50
2016 78.70
2015 48.30
Download all data from 2007 to 2019

How does Canada rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Netherlands
132 2019 +3.9 % +3.5 % View data
2 #2
Spain
129 2019 +2.8 % +0.6 % View data
9 #9
Sweden
83 2019 +3.3 % +2.5 % View data
10 #10
Canada
80 2019 +2.7 % +11.3 % View data
11 #11
Hungary
79 2019 +4.1 % +4.9 % View data
Compare all 28 countries

Go Top